Head and Neck Cancer
📧 Sign up to get email alerts when something new happens for Head and Neck Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer [Phase 1]
Phase 1 clinical trial evaluating the combination of Urelumab and Cetuximab in patients with advanced/metastatic colorectal cancer or advanc…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer [Phase 2]
This clinical trial update summarizes a Phase 2 study of trastuzumab in patients with advanced salivary gland cancer, which has completed en…
-
CLINICAL_TRIALS trial_result · 2017-04-18Clinical Trial Update: Ensuring Communication in Hospice by Oncology Study (ECHO) [NA]
The ECHO hospice communication trial, sponsored by Massachusetts General Hospital, has completed and involved patients with ovarian, cervica…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of erlotinib and celecoxib with reirradiation in recurrent head and neck cancer; results posted i…
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: The Biodistribution and Potential Diagnostic Ability of 18F FACBC in Patients With Head and Neck, Breast, and Prostate Cancer [NA]
This trial update describes the biodistribution and potential diagnostic use of the PET tracer 18F FACBC in patients with breast cancer, hea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-04-10Clinical Trial Update: The Fibrosis-Lymphedema Continuum in Head and Neck Cancer
A completed clinical trial update examining the relationship between fibrosis and lymphedema in head and neck cancer. The report highlights …
-
CLINICAL_TRIALS research · 2017-04-07Clinical Trial Update: Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck Cancer
A completed clinical trial update detailing the development of a symptom checklist to identify lymphedema symptoms in patients with head and…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer
Completed clinical trial assessing how secondary lymphedema after head and neck cancer treatment influences symptoms, functional status, and…
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: Neurocognitive Functioning in Patients With Newly Diagnosed Upper Aerodigestive Tract Cancer Receiving Treatment at Henry-Joyce Cancer Clinic
A completed clinical trial evaluating neurocognitive functioning in patients with newly diagnosed upper aerodigestive tract cancers undergoi…
-
CLINICAL_TRIALS trial_result · 2017-04-05Clinical Trial Update: Evaluation of Intraoperative Usage of Sentinella in Detecting Sentinel Lymph Nodes [NA]
This document reports completed clinical trial evaluating the intraoperative use of Sentinella to detect sentinel lymph nodes.
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Image Guided Adaptive Radiotherapy in the Head-and-neck Region [NA]
This clinical trial update reports completion and posting of results for a study on image-guided adaptive radiotherapy for head and neck can…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Acute and Longlasting Side Effects Caused by Radiotherapy in the Head and Neck Area
The document provides an update on a completed clinical trial examining acute and long-lasting side effects caused by radiotherapy in head a…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Feasibility Study of Dynasplint to Prevent Trismus in Head and Neck Cancer [NA]
This update reports a completed feasibility study evaluating the Dynasplint device to prevent trismus in patients with head and neck cancer.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Pain Related to Head and Neck Cancer (HNC); Implementation and Evaluation of Self-care Measure Due to the Same Illness [NA]
Completed clinical trial update evaluating self-care measures to manage pain in head and neck cancer. The study focused on implementing and …
-
FDA approval · 2017-03-17FDA Approved: CISPLATIN — Original Application (Sagent Pharmaceuticals)
FDA approved Sagent Pharmaceuticals' original application for cisplatin, a generic injectable chemotherapy agent (ANDA approval).
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Study of Proteins in Head and Neck Cancer Cells
Completed clinical trial investigating proteins in head and neck cancer cells sponsored by Vanderbilt University Medical Center.
-
CLINICAL_TRIALS research · 2017-03-14Clinical Trial Update: DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the Oropharynx
The document reports a completed study involving DNA analysis of tumor tissue from patients with HPV-associated oropharyngeal cancer. The wo…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Biomarkers in Patients With Head and Neck Cancer and in Healthy Volunteers
A completed clinical trial from Vanderbilt University Medical Center investigating biomarkers in patients with head and neck cancer and in h…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer
A completed clinical trial from Vanderbilt University Medical Center investigates germline mutations in patients with head and neck cancer w…
-
CLINICAL_TRIALS research · 2017-03-10Clinical Trial Update: Clinic Study of 18F-Al-NOTA-PRGD2 in Cancer Diagnostics [Phase 1]
Phase 1 clinical trial evaluating 18F-Al-NOTA-PRGD2 as a cancer imaging agent; the trial status is currently unknown.
-
CLINICAL_TRIALS trial_result · 2017-03-06Clinical Trial Update: SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 clinical trial update for SB-715992 in patients with recurrent or metastatic head and neck cancer; the study completed and results w…
-
CLINICAL_TRIALS withdrawal · 2017-03-03Clinical Trial Update: Trial to Determine Optimal Phase II Dose of the Oral Dual CAIX Inhibitor/ Radiosensitizer [Phase 1]
The trial to determine the optimal Phase II dose of an oral dual CAIX inhibitor/radiosensitizer for solid tumors, including head and neck ca…
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Title XELOX FOR SALIVARY GLAND CANCERS [Phase 2]
Phase 2 study of the XELOX regimen (capecitabine plus oxaliplatin) for salivary gland cancers and head and neck cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: A Study of Dasatinib, Cetuximab and Radiation With or Without Cisplatin in HNSCC [Phase 1]
Phase 1 study evaluating dasatinib, cetuximab, and radiation with or without cisplatin in head and neck cancer; trial terminated with result…
-
CLINICAL_TRIALS research · 2017-02-13Clinical Trial Update: Calcium Electroporation for Head and Neck Cancer [Phase 1]
An early-phase clinical trial update investigating calcium electroporation for head and neck cancer.